NASDAQ:CASI

CASI Pharmaceuticals News Headlines

$1.64
-0.07 (-3.80 %)
(As of 06/15/2021 02:36 PM ET)
Add
Compare
Today's Range
$1.64
$1.71
50-Day Range
$1.42
$2.15
52-Week Range
$1.32
$3.90
Volume6,838 shs
Average Volume818,044 shs
Market Capitalization$229.97 million
P/E RatioN/A
Dividend YieldN/A
Beta0.15

CASI Pharmaceuticals (NASDAQ CASI) News Headlines Today

SourceHeadline
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Expected to Announce Earnings of -$0.09 Per ShareCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Expected to Announce Earnings of -$0.09 Per Share
americanbankingnews.com - June 14 at 9:12 PM
Zacks: Brokerages Anticipate CASI Pharmaceuticals, Inc. (NASDAQ:CASI) to Post -$0.09 EPSZacks: Brokerages Anticipate CASI Pharmaceuticals, Inc. (NASDAQ:CASI) to Post -$0.09 EPS
americanbankingnews.com - June 14 at 9:12 PM
Need To Know: CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Insiders Have Been Buying SharesNeed To Know: CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Insiders Have Been Buying Shares
finance.yahoo.com - June 10 at 8:46 AM
CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple MyelomaCASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma
finance.yahoo.com - June 10 at 8:46 AM
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest UpdateCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Update
americanbankingnews.com - June 2 at 2:20 AM
$6.15 Million in Sales Expected for CASI Pharmaceuticals, Inc. (NASDAQ:CASI) This Quarter$6.15 Million in Sales Expected for CASI Pharmaceuticals, Inc. (NASDAQ:CASI) This Quarter
americanbankingnews.com - May 29 at 2:56 AM
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Expected to Announce Quarterly Sales of $6.15 MillionCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Expected to Announce Quarterly Sales of $6.15 Million
americanbankingnews.com - May 29 at 2:56 AM
 Brokerages Anticipate CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Will Announce Earnings of -$0.09 Per Share Brokerages Anticipate CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Will Announce Earnings of -$0.09 Per Share
americanbankingnews.com - May 27 at 11:18 AM
Zacks: Analysts Expect CASI Pharmaceuticals, Inc. (NASDAQ:CASI) to Announce -$0.09 EPSZacks: Analysts Expect CASI Pharmaceuticals, Inc. (NASDAQ:CASI) to Announce -$0.09 EPS
americanbankingnews.com - May 27 at 11:18 AM
CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare ConferenceCASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 27 at 8:44 AM
CASI Pharmaceuticals (NASDAQ:CASI) Receives New Coverage from Analysts at BTIG ResearchCASI Pharmaceuticals (NASDAQ:CASI) Receives New Coverage from Analysts at BTIG Research
americanbankingnews.com - May 24 at 9:58 AM
Return On Capital Employed Overview: CASI PharmaceuticalsReturn On Capital Employed Overview: CASI Pharmaceuticals
benzinga.com - May 21 at 7:14 PM
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Just Released Its First-Quarter Results And Analysts Are Updating Their EstimatesCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
nasdaq.com - May 17 at 7:58 PM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating CASI Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty ClaimsINVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating CASI Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - May 17 at 2:57 PM
CASI Pharmaceuticals, Inc. Common Stock (CASI)CASI Pharmaceuticals, Inc. Common Stock (CASI)
nasdaq.com - May 13 at 11:27 PM
CASI Pharmaceuticals: Q1 Earnings InsightsCASI Pharmaceuticals: Q1 Earnings Insights
benzinga.com - May 13 at 12:11 PM
CASI Pharmaceuticals Announces First Quarter 2021 Financial ResultsCASI Pharmaceuticals Announces First Quarter 2021 Financial Results
finance.yahoo.com - May 13 at 7:10 AM
Heres what Wall Street expects from CASI Pharmaceuticalss earningsHere's what Wall Street expects from CASI Pharmaceuticals's earnings
markets.businessinsider.com - May 12 at 10:44 AM
These 2 Penny Stocks Could Rally Over 100%, Says OppenheimerThese 2 Penny Stocks Could Rally Over 100%, Says Oppenheimer
finance.yahoo.com - April 28 at 2:40 PM
What Type Of Returns Would CASI Pharmaceuticals(NASDAQ:CASI) Shareholders Have Earned If They Purchased Their Shares Three Years Ago?What Type Of Returns Would CASI Pharmaceuticals'(NASDAQ:CASI) Shareholders Have Earned If They Purchased Their Shares Three Years Ago?
finance.yahoo.com - April 26 at 9:09 AM
Spectrum Pharmaceuticals Inc (SPPI) Q4 2020 Earnings Call TranscriptSpectrum Pharmaceuticals Inc (SPPI) Q4 2020 Earnings Call Transcript
nasdaq.com - March 30 at 11:47 PM
CASI Pharmaceuticals Announces Full Year 2020 Financial ResultsCASI Pharmaceuticals Announces Full Year 2020 Financial Results
finance.yahoo.com - March 30 at 8:45 AM
CASI Pharmaceuticals To Host Business Update Call March 12, 2021CASI Pharmaceuticals To Host Business Update Call March 12, 2021
finance.yahoo.com - March 11 at 5:46 PM
CASI Pharmaceuticals To Develop CB-5339 In Cancer Indications In ChinaCASI Pharmaceuticals To Develop CB-5339 In Cancer Indications In China
finance.yahoo.com - March 8 at 1:28 PM
Cleave Therapeutics Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI Pharmaceuticals For Greater China RegionCleave Therapeutics Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI Pharmaceuticals For Greater China Region
finance.yahoo.com - March 8 at 8:27 AM
Were Hopeful That CASI Pharmaceuticals (NASDAQ:CASI) Will Use Its Cash WiselyWe're Hopeful That CASI Pharmaceuticals (NASDAQ:CASI) Will Use Its Cash Wisely
finance.yahoo.com - February 25 at 10:24 AM
CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business UpdatesCASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business Updates
finance.yahoo.com - February 16 at 8:34 AM
CASI Pharmaceuticals Partner, BioInvent, Presents Phase I/IIA Data That Suggests BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkins Lymphoma PatientsCASI Pharmaceuticals Partner, BioInvent, Presents Phase I/IIA Data That Suggests BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients
finance.yahoo.com - January 28 at 7:28 AM
CASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion Leader Call On BI-1206 For Relapsed Or Refractory Non-Hodgkins LymphomaCASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion Leader Call On BI-1206 For Relapsed Or Refractory Non-Hodgkin's Lymphoma
finance.yahoo.com - January 21 at 7:58 AM
What Type Of Shareholders Make Up CASI Pharmaceuticals, Inc.s (NASDAQ:CASI) Share Registry?What Type Of Shareholders Make Up CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Share Registry?
finance.yahoo.com - January 11 at 7:21 AM
BUZZ-U.S. STOCKS ON THE MOVE-Cellectar Biosciences, CASI Pharmaceuticals, PfizerBUZZ-U.S. STOCKS ON THE MOVE-Cellectar Biosciences, CASI Pharmaceuticals, Pfizer
nasdaq.com - December 24 at 11:51 PM
CASI Pharmaceuticals Announces Appointment Of Chief Financial OfficerCASI Pharmaceuticals Announces Appointment Of Chief Financial Officer
finance.yahoo.com - December 16 at 7:41 AM
Is CASI A Good Stock To Buy Now?Is CASI A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 6:52 PM
CASI: Raising target price on pipeline progressCASI: Raising target price on pipeline progress
finance.yahoo.com - November 30 at 5:05 PM
Chairman & CEO Wei-Wu He Just Bought 4.7% More Shares In CASI Pharmaceuticals, Inc. (NASDAQ:CASI)Chairman & CEO Wei-Wu He Just Bought 4.7% More Shares In CASI Pharmaceuticals, Inc. (NASDAQ:CASI)
finance.yahoo.com - November 27 at 9:21 AM
Wednesday 11/25 Insider Buying Report: CASI, CHMAWednesday 11/25 Insider Buying Report: CASI, CHMA
nasdaq.com - November 25 at 1:39 PM
Casi Pharmaceuticals jumps 6% after CEO buys 227.5K sharesCasi Pharmaceuticals jumps 6% after CEO buys 227.5K shares
seekingalpha.com - November 25 at 8:39 AM
Casi Pharmaceuticals jumps 6% after CEO buys $488K in common stockCasi Pharmaceuticals jumps 6% after CEO buys $488K in common stock
seekingalpha.com - November 25 at 8:39 AM
Juventas initiates registration study for CNCT19Juventas initiates registration study for CNCT19
seekingalpha.com - November 19 at 3:46 AM
CASI Pharmaceuticals Announces Partner Juventas Completes $65 Million Financing And Initiates Registration Study For CNCT19 (CD19 CAR-T)CASI Pharmaceuticals Announces Partner Juventas Completes $65 Million Financing And Initiates Registration Study For CNCT19 (CD19 CAR-T)
finance.yahoo.com - November 18 at 10:32 PM
CASI Pharmaceuticals, Inc. to Host Earnings CallCASI Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 6:19 PM
CASI Pharmaceuticals: Q3 Earnings InsightsCASI Pharmaceuticals: Q3 Earnings Insights
finance.yahoo.com - November 9 at 1:18 PM
CASI Pharmaceuticals EPS misses by $0.08, beats on revenueCASI Pharmaceuticals EPS misses by $0.08, beats on revenue
seekingalpha.com - November 9 at 8:18 AM
CASI Pharmaceuticals Announces Third Quarter 2020 Financial ResultsCASI Pharmaceuticals Announces Third Quarter 2020 Financial Results
finance.yahoo.com - November 9 at 8:18 AM
How Many CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Shares Did Insiders Buy, In The Last Year?How Many CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Shares Did Insiders Buy, In The Last Year?
finance.yahoo.com - November 6 at 8:40 AM
CASI Pharmaceuticals To Report Third Quarter 2020 Financial Results And Host Conference Call November 9, 2020CASI Pharmaceuticals To Report Third Quarter 2020 Financial Results And Host Conference Call November 9, 2020
finance.yahoo.com - November 5 at 2:13 PM
CASI and BioInvent enter into an exclusive license agreement for BI-1206CASI and BioInvent enter into an exclusive license agreement for BI-1206
seekingalpha.com - October 27 at 2:40 PM
BioInvent licenses anti-FcyRIIB antibody BI-1206 to CASI Pharmaceuticals for Greater China regionBioInvent licenses anti-FcyRIIB antibody BI-1206 to CASI Pharmaceuticals for Greater China region
finanznachrichten.de - October 27 at 9:39 AM
CASI Pharmaceuticals restructures Juventas Cell Therapy partnershipCASI Pharmaceuticals restructures Juventas Cell Therapy partnership
seekingalpha.com - September 29 at 1:46 PM
CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy LtdCASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd
marketwatch.com - September 29 at 8:46 AM
This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at conta[email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.